United States · FDA National Drug Code directory
Guaifenesin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71179-002_92017a98-db41-475b-bccf-cab449b6d56c
- Product NDC
- 71179-002
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guaifenesin
- Labeler
- VESPYR BRANDS LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220627
- Source listing expiry
- 20271231
Source-listed ingredients
- GUAIFENESIN — 1200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (71179-002-21) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 71179-002-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →